Somatic mutation of epidermal growth factor receptor in a small subset of cutaneous squamous cell carcinoma

Journal of Investigative Dermatology

Volumn 130, Issue 3, 2010, Pages 901-903

  Ridd, Katie ^a   Bastian, Boris C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 3; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE;

ACANTHOSIS NIGRICANS; CELL PROLIFERATION; CRANIOFACIAL SYNOSTOSIS; CROUZON SYNDROME; ENZYME ACTIVATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; HEAD AND NECK CARCINOMA; HUMAN; HYBRIDIZATION; KERATOACANTHOMA; LETTER; MELANOMA; METASTASIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; SKIN CANCER; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA;

EID: 76649128067     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2009.312     Document Type: Letter

References (27)

1. Amit I, Citri A, Shay T, Lu Y, Katz M, Zhang F et al. (2007) A module of negative feedback regulators defines growth factor signaling. Nat Genet 4:503-512
2. Bauknecht T, Gross G, Hagedorn M (1985) Epidermal growth factor receptors in different skin tumors. Dermatologica 1:16-20
3. Berk DR, Spector EB, Bayliss SJ (2007) Familial acanthosis nigricans due to K650T FGFR3 mutation. Arch Dermatol 9:1153-1156
4. Cappellen D, De Oliveira C, Ricol D, de Medina S, Bourdin J, Sastre-Garau X et al. (1999) Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas. Nat Genet 1:18-20
5. Citri A, Yarden Y (2006) EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol 7:505-516
6. Conde E, Angulo B, Tang M, Morente M, Torres-Lanzas J, Lopez-Encuentra A et al. (2006) Molecular context of the EGFR mutations: evidence for the activation of mTOR/S6K signaling. Clin Cancer Res 3(Pt 1):710-717
7. De Moerlooze L, Spencer-Dene B, Revest JM, Hajihosseini M, Rosewell I, Dickson C (2000) An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. Development 3:483-492
8. Di Renzo MF, Olivero M, Martone T, Maffe A, Maggiora P, Stefani AD et al. (2000) Somatic mutations of the MET onco-gene are selected during metastatic spread of human HNSC carcinomas. Oncogene 12:1547-1555
9. Euvrard S, Kanitakis J, Claudy A (2003) Skin cancers after organ transplantation. N Engl J Med 17:1681-1691
10. Han SW, Kim TY, Hwang PG, Jeong S, Kim J, Choi IS et al. (2005) Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib. J Clin Oncol 11:2493-2501
11. Hosokawa S, Toyooka S, Fujiwara Y, Tokumo M, Soh J, Takigawa N et al. (2009) Comprehensive analysis of EGFR signaling pathways in Japanese patients with non-small cell lung cancer. Lung Cancer 66:107-113
12. Kan SH, Elanko N, Johnson D, Cornejo-Roldan L, Cook J, Reich EW; et al. (2002) Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis. Am J Hum Genet 2:472-486
13. Karoui M, Hofmann-Radvanyi H, Zimmermann U, Couvelard A, Degott C, Faridoni-Laurens L et al. (2001) No evidence of somatic FGFR3 mutation in various types of carcinoma. Oncogene 36:5059-5061
14. Kiguchi K, Bol D, Carbajal S, Beltran L, Moats S, Chan K et al. (2000) Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development. Onco-gene 37:4243-4254 (Pubitemid 30750922)
15. Lindner G, Menrad A, Gherardi E, Merlino G, Welker P, Handjiski B et al. (2000) Involvement of hepatocyte growth factor/scatter factor and met receptor signaling in hair follicle morphogenesis and cycling. Faseb J 2:319-332
16. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor I (IGF-1) and type 1 IGF receptor (IGF1R). Cell 1:59-72
17. Logie A, Dunois-Larde C, Rosty C, Levrel O, Blanche M, Ribeiro A et al. (2005) Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans. Hum Mol Genet 9:1153-1160
18. Maubec E, Duvillard P, Velasco V, Crickx B, Avril MF (2005) Immunohistochemical analysis of EGFR and HER-2 in patients with metastatic squamous cell carcinoma of the skin. Anticancer Res 2B: 1205-1210
19. Meyers GA, Orlow SJ, Munro IR, Przylepa KA, Jabs EW (1995) Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigri-cans. Nat Genet 4:462-464
20. Pallis AG, Voutsina A, Kalikaki A, Souglakos J, Briasoulis E, Murray S et al. (2007) 'Classical' but not 'other' mutations of EGFR kinase domain are associated with clinical outcome in gefitinib-treated patients with non-small cell lung cancer. Br J Cancer 11:1560-1566
21. Pollock PM, Gartside MG, Dejeza LC, Powell MA, Mallon MA, Davies H et al. (2007) Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes. Oncogene 50:7158-7162
22. Schmidt L, Junker K, Nakaigawa N, Kinjerski T, Weirich G, Miller M et al. (1999) Novel mutations of the MET proto-oncogene in papillary renal carcinomas. Oncogene 14:2343-2350
23. Shimizu T, Izumi H, Oga A, Furumoto H, Murakami T, Ofuji R et al. (2001) Epidermal growth factor receptor overexpression and genetic aberrations in metastatic squamous-cell carcinoma of the skin. Dermatology 3:203-206
24. Sonobe M, Nakagawa M, Takenaka K, Katakura H, Adachi M, Yanagihara K et al. (2007) Influence of epidermal growth factor receptor (EGFR) gene mutations on the expression of EGFR, phosphoryl-Akt, and phosphoryl-MAPK, and on the prognosis of patients with non-small cell lung cancer. J Surg Oncol 1:63-69
25. Vicent S, Lopez-Picazo JM, Toledo G, Lozano MD, Torre W, Garcia-Corchon C et al. (2004) ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours. Br J Cancer 5:1047-1052
26. Weichselbaum RR, Dunphy EJ, Beckett MA, Tybor AG, Moran WJ, Goldman ME et al. (1989) Epidermal growth factor receptor gene amplification and expression in head and neck cancer cell lines. Head Neck 5:437-442
27. Willmore-Payne C, Holden JA, Layfield LJ (2006) Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression. Hum Pathol 6:755-763